METHOTREXATE

You have access
Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results
Arthur N. Lau, J. Carter Thorne, Mohammad Movahedi, Emmanouil Rampakakis, Angela Cesta, Xiuying Li, Sandra Couto, John Sampalis, Claire Bombardier and the OBRI Investigators

The Journal of Rheumatology August 1 2019, 46 (8) 874-886; DOI: https://doi.org/10.3899/jrheum.180486
You have access
Serum Biomarkers for Prediction of Response to Methotrexate Monotherapy in Early Rheumatoid Arthritis: Results from the SWEFOT Trial
Karen Hambardzumyan, Rebecca J. Bolce, Johan K. Wallman, Ronald F. van Vollenhoven and Saedis Saevarsdottir

The Journal of Rheumatology June 1 2019, 46 (6) 555-563; DOI: https://doi.org/10.3899/jrheum.180537
You have access
Associations Between Methotrexate Use and the Risk of Cardiovascular Events in Patients with Elderly-onset Rheumatoid Arthritis
Jessica Widdifield, Michal Abrahamowicz, J. Michael Paterson, Anjie Huang, J. Carter Thorne, Janet E. Pope, Bindee Kuriya, Marie-Eve Beauchamp and Sasha Bernatsky

The Journal of Rheumatology May 1 2019, 46 (5) 467-474; DOI: https://doi.org/10.3899/jrheum.180427
You have access
Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study
Matthew J. Koster, Karthik Yeruva, Cynthia S. Crowson, Francesco Muratore, Cristian Labarca and Kenneth J. Warrington

The Journal of Rheumatology May 1 2019, 46 (5) 501-508; DOI: https://doi.org/10.3899/jrheum.180429
You have access
Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate
Gurjit S. Kaeley, Daryl K. MacCarter, Aileen L. Pangan, Xin Wang, Jasmina Kalabic and Veena K. Ranganath

The Journal of Rheumatology December 1 2018, 45 (12) 1628-1635; DOI: https://doi.org/10.3899/jrheum.171232
Open Access
CNTO6785, a Fully Human Antiinterleukin 17 Monoclonal Antibody, in Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: A Randomized, Placebo-controlled, Phase II, Dose-ranging Study
Philip J. Mease, Slawomir Jeka, Juan Jose Jaller, Tasanee Kitumnuaypong, Worawit Louthrenoo, Herman Mann, Galina Matsievskaia, Enrique R. Soriano, Bin Jia, Caihong Wang, Jing Nie and Elizabeth Hsia

The Journal of Rheumatology January 1 2018, 45 (1) 22-31; DOI: https://doi.org/10.3899/jrheum.161238
You have access
Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis
Mojca Zajc Avramovič, Vita Dolžan, Nataša Toplak, Meta Accetto, Lara Lusa and Tadej Avčin

The Journal of Rheumatology August 1 2017, 44 (8) 1216-1223; DOI: https://doi.org/10.3899/jrheum.160950
Open Access
Five-year Efficacy and Safety of Tocilizumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Methotrexate- and Biologic-naive or Free of Methotrexate for 6 Months: the AMBITION Study
Graeme Jones, Thomas Wallace, Matthew J. McIntosh, Laura Brockwell, Juan J. Gómez-Reino and Anthony Sebba

The Journal of Rheumatology February 1 2017, 44 (2) 142-146; DOI: https://doi.org/10.3899/jrheum.160287
You have access
Differences in Predictive Factors for Sustained Clinical Remission with Abatacept Between Younger and Elderly Patients with Biologic-naive Rheumatoid Arthritis: Results from the ABROAD Study
Masahiro Sekiguchi, Takao Fujii, Kiyoshi Matsui, Kosaku Murakami, Satoshi Morita, Koichiro Ohmura, Yutaka Kawahito, Norihiro Nishimoto, Tsuneyo Mimori, Hajime Sano and The ABROAD Study Investigators

The Journal of Rheumatology November 1 2016, 43 (11) 1974-1983; DOI: https://doi.org/10.3899/jrheum.160051
Open Access
Adherence and Persistence with Methotrexate in Rheumatoid Arthritis: A Systematic Review
Jeffrey R. Curtis, Vivian P. Bykerk, Maher Aassi and Michael Schiff

The Journal of Rheumatology November 1 2016, 43 (11) 1997-2009; DOI: https://doi.org/10.3899/jrheum.151212

Main menu

User menu

Search

METHOTREXATE

Pages

Content

Resources

Subscribers

More